Glucose Monitoring Devices Market Worldwide (2010 - 2014)

July 2009 | 44 pages | ID: GC0A80E4965EN
Renub Research

Abstracts

“Glucose Monitoring Devices Market Worldwide (2010 – 2014)” report is an essential source of data and analysis on the Blood Glucose Monitoring Devices Market with complete coverage by categories. The report provides market landscape and market trends information. The report identifies the key trends shaping and driving the dynamism in the global blood glucose monitoring devices market. The report provides insight on the emerging key players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the opportunities within the global blood glucose monitoring market. This report investigates the Worldwide, USA, Europe, India, China, Japan, Malaysia, Taiwan, South Korea, Indonesia, Singapore, Thailand, Philippines, Australia blood glucose monitoring devices market.

Research Highlights

• Worldwide Glucose monitoring devices market is expected to be more than US$ 16 Billion by 2014
• Roche Diagnostics & Life Scan together controlled 65% of the global glucose meter market in 2008
• USA glucose monitoring devices market sales has crossed US$ 2.5 Billion by 2009
• Europe glucose monitoring devices market is expected be more than double the USA market by 2014
• Japan glucose monitoring devices market is expected to grow with a CAGR of 28.6% for the period of 2010 to 2014
• India number of diabetes patients has crossed 50 Million mark by 2010
• India glucose monitoring devices market is expected to more than US$ 100 Million by 2014
• China glucose monitoring devices market is expected to be more than US$ 150 Million by 2014

Countries Covered

Worldwide, USA, Europe, India, China, Japan, Malaysia, Singapore, Thailand, Philippines, South Korea, Taiwan, Australia

Key Players Analyzed

This section covers the key facts about the major players in blood glucose monitoring market The key players analyzed in this section are Roche, Abbott Laboratories, Bayer AG, Lifescan Inc., Terumo Corporation, Arkray Inc.

Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations.

Contents

1. EXECUTIVE SUMMARY

2. WORLDWIDE DIABETES POPULATION & GLUCOSE MONITORING DEVICES MARKET

2.1 Diabetes Population & Future Scenario
2.2 Glucose Monitoring Devices Market
2.3 By Company Global Glucose Monitoring Market Share
2.4 United States
  2.4.1 USA Diabetes Population & Future Scenario
  2.4.2 USA Glucose Monitoring Devices Market & Future Forecast
2.5 Europe
  2.5.1 Europe Diabetes Population & Future Scenario
  2.5.2 Europe Glucose Monitoring Devices Market & Future Forecast
2.6 India
  2.6.1 India Diabetes Population & Future Scenario
  2.6.2 India Glucose Monitoring Devices Market & Future Forecast
2.7 China
  2.7.1 China Diabetes Population & Future Scenario
  2.7.2 China Glucose Monitoring Devices Market & Future Forecast
2.8 Japan
  2.8.1 Japan Diabetes Population & Future Scenario
  2.8.2 Japan Glucose Monitoring Devices Market & Future Forecast
2.9 Malaysia
  2.9.1 Malaysia Diabetes Population & Future Scenario
  2.9.2 Malaysia Glucose Monitoring Devices Market for 2007
2.10 Singapore
  2.10.1 Singapore Diabetes Population & Future Scenario
  2.10.2 Singapore Glucose Monitoring Devices Market for 2007
2.11 Thailand
  2.11.1 Thailand Diabetes Population & Future Scenario
  2.11.2 Thailand Glucose Monitoring Devices Market for 2007
2.12 Philippines
  2.12.1 Philippines Diabetes Population & Future Scenario
  2.12.2 Philippines Glucose Monitoring Devices Market for 2007
2.13 South Korea
  2.13.1 South Korea Diabetes Population & Future Scenario
  2.13.2 South Korea Glucose Monitoring Devices Market for 2007
2.14 Taiwan
  2.14.1 Taiwan Diabetes Population & Future Scenario
  2.14.2 Taiwan Glucose Monitoring Devices Market for 2007
2.15 Australia
  2.15.1 Australia Diabetes Population & Future Scenario
  2.15.2 Australia Glucose Monitoring Devices Market & Future Forecast

3. KEY PLAYERS

3.1 Abbott Laboratories
3.2 Bayer AG
3.3 Roche
3.4 Lifescan Inc.
3.5 Terumo Corporation
3.6 Arkray Inc.

List Of Figures

LIST OF FIGURES:

Figure 2 1: Worldwide – Glucose Monitoring Devices Market (Billion US$), 2000 – 2009
Figure 2 2: Global – Forecast for Glucose Monitoring Devices Market (Billion US$), 2010 – 2014
Figure 2 3: Worldwide – By Company Glucose Monitoring Devices Market Share, 2008
Figure 2 4: USA – Number of Diabetes Patients (Million), 2003, 2006, 2007 & 2010
Figure 2 5: USA – Glucose Monitoring Devices Market (Billion US$), 2004 – 2009
Figure 2 6: USA – Forecast for Glucose Monitoring Devices Market (Billion US$), 2010 – 2014
Figure 2 7: Europe – Glucose Monitoring Devices Market (Billion US$), 2004 – 2009
Figure 2 8: Europe – Forecast for Glucose Monitoring Devices Market (Billion US$), 2010 – 2014
Figure 2 9: India – Number of People with Diabetes (Million), 2003, 2007, 2010
Figure 2 10: India – Glucose Monitoring Devices Market (Million US$), 2000 – 2009
Figure 2 11: India – Forecast for Glucose Monitoring Devices Market (Million US$), 2010 – 2014
Figure 2 12: China – Number of Diabetes Patients (Million), 2003, 2007 & 2010
Figure 2 13: China – Glucose Monitoring Devices Market (Million US$), 2006 – 2009
Figure 2 14: China – Forecast for Glucose Monitoring Devices Market (Million US$), 2010 – 2014
Figure 2 15: Japan – Number of Diabetes Population (Million), 2003 – 2010
Figure 2 16: Japan – Glucose Monitoring Devices Market (Billion JPY), 2005 – 2009
Figure 2 17: Japan – Forecast for Glucose Monitoring Devices Market (Billion JPY), 2010 – 2014
Figure 2 18: Australia – Glucose Monitoring Devices Market (Million US$), 2010 – 2014

List Of Tables

LIST OF TABLES:

Table 2 1: Regional – Estimates for (Number of People with Diabetes, Comparative Diabetes Prevalence %) (20-79 years), 2010 and 2030
Table 2 2: USA – Forecast for Number of Diabetes Patients (Million), 2011 – 2030
Table 2 3: Europe – Forecast for Number of People with Diabetes (Million), 2010 – 2030
Table 2 4: India – Forecast for Number of People with Diabetes (Million), 2011 – 2030
Table 2 5: China – Forecast for Number of Diabetes Patients (Million), 2011 – 2030
Table 2 6: Japan – Forecast for Number of Diabetes Patients (Million), 2010 – 2030
Table 2 7: Malaysia – Forecast for Number of Diabetes Patients (Million), 2010 – 2030
Table 2 8: Malaysia – Glucose Monitoring Devices Market (Million US$), 2007
Table 2 9: Singapore – Forecast for Number of Diabetes Patients (Thousand), 2010 – 2030
Table 2 10: Singapore – Glucose Monitoring Devices Market (Million US$), 2007
Table 2 11: Thailand – Forecast for Number of Diabetes Patients (Million), 2010 – 2030
Table 2 12: Thailand – Glucose Monitoring Devices Market (Million US$), 2007
Table 2 13: Philippines – Number of Diabetes Patients (Million), 2010 – 2030
Table 2 14: Philippines – Glucose Monitoring Devices Market (Million US$), 2007
Table 2 15: South Korea – Forecast for Number of Diabetes Patients (Million), 2010 – 2030
Table 2 16: South Korea – Glucose Monitoring Devices Market (Million US$), 2007
Table 2 17: Taiwan – Forecast for Number of Diabetes Patients (Thousand), 2010 – 2030
Table 2 18: Taiwan – Glucose Monitoring Devices Market (Million US$), 2007
Table 2 19: Australia – Number of Diabetes Patients (Million), 2010 – 2030
Table 3 1: Abbott Laboratories – Key Financials (Million US$) 2007 – 2009
Table 3 2: Bayer AG – Key Financials (Million US$) 2006 – 2008
Table 3 3: Roche – Key Financials (Million US$) 2007 – 2009
Table 3 4: Terumo Corporation – Key Financials (Million US$) 2007 – 2009